Australia has a notable opportunity in biotechnology, with ribonucleic acid (RNA) therapies and technologies primarily in the research phase, focusing on vaccines, protein therapies, cancer treatment and biopesticides.
The reform offers Australia the opportunity to determine how health and medical research can better fit the nation’s needs now and into the future.
Through research and consultation with multi-disciplinary experts, this report has identified the key challenges and opportunities for Australia to improve prevention, detection, diagnosis, and response to drug-resistant infections and reduce the impacts of antimicrobial resistance.
Australia’s research system is a key contributor to Australia’s economic, social and environmental prosperity. The Academy encourages efforts to increase the efficiency and effectiveness of Australia’s research funding systems.
Report on Australia Israel Researcher Exchange Program - Australian Delegation to Israel Neuroscience Workshop and associated technical visits, held in conjunction with the Israel Society for Neuroscience (ISFN) Annual Meeting.
Diversity and Inclusion
Reconciliation Action Plan Diversity and inclusion policy Diversity & Inclusion ToolkitConnect
Australian Academy of Technological Sciences & Engineering
Level 2, 28 National Circuit Forrest ACT 2603
+61 2 6185 3240 | info@atse.org.au
ABN 58 008 520 394 — ATSE is registered with the Australian Charities and Not-for-profits Commission,
and is a Deductible Gift Recipient (DGR).
